Prevalence of rheumatoid arthritis in Germany based on health insurance data. Regional differences and first results of the PROCLAIR study

被引:42
作者
Hense, S. [1 ,2 ]
Ramos, A. Luque [1 ]
Callhoff, J. [3 ]
Albrecht, K. [3 ]
Zink, A. [3 ,4 ]
Hoffmann, F. [1 ]
机构
[1] Carl von Ossietzky Univ Oldenburg, Dept Versorgungsforsch, Fak Med & Gesundheitswissensch, Ammerlander Heerstr 140, D-26111 Oldenburg, Germany
[2] Robert Koch Inst, Abt Epidemiol & Gesundheitsmonitoring, Berlin, Germany
[3] Deutsch Rheumaforschungszentrum Berlin, Programmbereich Epidemiol, Berlin, Germany
[4] Charite, Klin Schwerpunkt Rheumatol & Klin Immunol, Berlin, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2016年 / 75卷 / 08期
关键词
Rheumatoid arthritis; Epidemiology; Secondary data; Health services research; Healthcare insurance data; VALIDATION; SMOKING; RISK;
D O I
10.1007/s00393-016-0088-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disease with a prevalence of up to 1 % in the adult population. This study describes the prevalence of RA diagnoses in outpatient health insurance claims data, based on different case definitions and stratified by age, sex and region of residence. Based on data from a nationwide statutory health insurance fund (BARMER GEK) from the year 2013, a cross-sectional study of insurants aged 18 years or older was conducted. The following case definitions were applied: A) a diagnosis of seropositive rheumatoid arthritis (M05) or other rheumatoid arthritis (M06) according to the international classification of diseases 10 German modification (ICD-10-GM) in at least two quarterly periods of the year 2013, B) case definition A plus determination of CaEuroreactive protein (CRP) or erythrocyte sedimentation rate (ESR) at least once, C) case definition B plus specific drug therapy and D) case definition A plus treatment by a rheumatologist. Raw as well as age and sex-standardized prevalences were calculated and stratified according to the federal state. The study population consisted of 7,155,315 insurants of whom 60.2 % were female. Overall, RA prevalences for the respective case definitions were 1.62 % (A), 1.11 % (B), 0.94 % (C) and 0.64 % (D). When standardized to the German population the prevalences were 1.38 % (A), 0.95 % (B), 0.81 % (C) and 0.55 % (D). The proportion of women was approximately 80 % for all case definitions. Prevalences increased with age, peaking in the age group 70-79 years old and showing the highest values in eastern and the lowest in southern Germany for raw as well as standardized measures. Regional differences in the prevalence of RA diagnoses in health insurance claims data were observed independent of age, sex and case definition. The expected prevalence according to the results of international studies was best achieved when case definitions with CRP or ESR were considered.
引用
收藏
页码:819 / 826
页数:8
相关论文
共 42 条
  • [21] Prevalence and Annual Health Insurance Cost of Endometriosis in Hungary-A Nationwide Study Based on Routinely Collected, Real-World Health Insurance Claims Data
    Csakvari, Timea
    Ponusz-Kovacs, Dalma
    Kajos, Luca Fanni
    Elmer, Diana
    Ponusz, Robert
    Kovacs, Bettina
    Varnagy, Akos
    Kovacs, Kalman
    Bodis, Jozsef
    Boncz, Imre
    HEALTHCARE, 2023, 11 (10)
  • [22] Does Coxitis Fugax Predispose for Later Perthes' Disease? - First Results of an Insurance Data-Based Study
    Stobbe, S.
    Pennekamp, P. H.
    Filler, T.
    Goedecke, S.
    Lieb, A.
    Placzek, R.
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2015, 153 (01): : 80 - 84
  • [23] The impossibility of mortality evaluation of skin cancer screening in Germany based on health insurance data: a case-control study
    Stang, Andreas
    Schuldt, Katrin
    Trocchi, Pietro
    Neusser, Silke
    Speckemeier, Christian
    Pahmeier, Kathrin
    Wasem, Juergen
    Lax, Hildegard
    Nonnemacher, Michael
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : 52 - 58
  • [24] Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data
    Neubauer, Sarah
    Zeidler, Henning
    Linder, Roland
    Zeidler, Jan
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (12) : E70 - E79
  • [25] Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data
    Jung, Seung Min
    Kwok, Seung-Ki
    Ju, Ji Hyeon
    Park, Yong-Boom
    Park, Sung-Hwan
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (03) : 669 - 677
  • [26] Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study
    Demmer, Ryan T.
    Molitor, Jerry A.
    Jacobs, David R., Jr.
    Michalowicz, Bryan S.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2011, 38 (11) : 998 - 1006
  • [27] Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance
    Kreft, D.
    Doblhammer, G.
    Guthoff, R. F.
    Frech, S.
    BMC PUBLIC HEALTH, 2019, 19 (1)
  • [28] Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance
    D. Kreft
    G. Doblhammer
    R. F. Guthoff
    S. Frech
    BMC Public Health, 19
  • [29] Prevalence, comorbidities, and disease-related complications of rheumatoid arthritis in Colombia: a national cross-sectional study based on administrative claims data
    Maldonado-Canon, Kevin
    Buitrago, Giancarlo
    Quintana-Lopez, Gerardo
    ADVANCES IN RHEUMATOLOGY, 2025, 65 (01):
  • [30] Which chronic diseases are associated with frequent attending of ambulatory medical care in the elderly population in Germany? - A study based on statutory health insurance data
    van den Bussche, Hendrik
    Niemann, Detlef
    Kaduszkiewicz, Hanna
    Schaefer, Ingmar
    Koller, Daniela
    Hansen, Heike
    Scherer, Martin
    Glaeske, Gerd
    Schoen, Gerhard
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2013, 107 (07): : 442 - 450